Take Solutions Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2025.
TAKE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 5.4 pts more than Nifty Microcap 250 and 4.8 pts more than its Healthcare Services peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
TAKE Solutions Limited submitted its unaudited standalone and consolidated financial results for the quarter ended June 30, 2025, along with a Limited Review Report from statutory auditors. The auditors issued a 'Qualified Conclusion' (modified opinion) on both sets of results, flagging a 'material uncertainty' on the company's ability to continue as a going concern. Key concerns include unrecoverable tax assets of ₹150 million, contingent tax liabilities of ₹150 million from pending litigations, and significant unpaid statutory dues. The Group carried out no operations during the current or previous financial year, and the previous year saw a huge loss after tax of ₹150 million, partly due to divestment of subsidiary Ecron Acunova Limited. The company is exploring diversification into other verticals and plans to solicit mutually rewarding business partnerships/mergers. There is no Managing Director, CEO, or Whole Time Director currently, as the executive director resigned in December 2024.
This is a deeply negative filing for shareholders. The qualified auditor opinion combined with an explicit going concern doubt signals serious financial distress. With the group effectively non-operational, pending tax litigations, and no permanent executive leadership in place, the stock carries significant risk and is likely to face continued downward pressure.